Prevalence and characteristics of the MMTV-like associated breast carcinomas in Tunisia

Cancer Letters

Volumn 271, Issue 2, 2008, Pages 222-230

  Hachana, M ^a   Trimeche, M ^a   Ziadi, S ^a   Amara, K ^a   Gaddas, N ^a   Mokni, M ^a   Korbi, S ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Breast cancer; Mouse mammary tumor virus; Tunisia

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOUSE MAMMARY TUMOR ONCOVIRUS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING; TUNISIA;

ADULT; BASE SEQUENCE; BREAST NEOPLASMS; DNA, VIRAL; FEMALE; HUMANS; MAMMARY TUMOR VIRUS, MOUSE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUNISIA;

MOUSE MAMMARY TUMOR VIRUS;

EID: 53249124661     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.06.001     Document Type: Article

References (50)

1. Hankinson S.E., Colditz G.A., and Willett W.C. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 6 (2004) 213-218
2. Labrecque L.G., Barnes D.M., Fentiman I.S., and Griffin B.E. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 55 (1995) 39-45
3. Bittner J.J. The milk influence of breast tumor in mice. Science 95 (1942) 462-463
4. Holder W.D., and Wells S.A. Antibody reacting with murine mammary tumour virus in the serum of patients with breast cancer: possible serological detection method for breast cancinoma. Cancer Res. 43 (1983) 239-244
5. Segev N., Hizi A., Kirenberg F., and Keydar I. Characterization of a protein, released by T47D cell-line, immunologically related to the major envelope protein of the mouse mammary tumour virus. Proc. Nat. Acad. Sci. USA 82 (1985) 1531-1535
6. Dion A.S., Girardi A.J., Williams C.C., Pomenti A.A., and Redfield E.S. Responses of serum from breast cancer patients to murine mammary tumour virus: fact or artefact?. J. Natl. Cancer Inst. 79 (1987) 207-211
7. Holland J.F., and Pogo B.G. Mouse mammary virus-like viral infection and human breast cancer. Clin. Cancer Res. 10 (2004) 5647-5649
8. Wang Y., Holland J.F., Bleiweiss I.J., Melana S., Liu X., Pelisson I., Cantarella A., Stellrecht K., Mani S., and Pogo B.G.-T. Detection of mammary tumor virus ENV gene-like sequences in human breast cancer. Cancer Res. 55 (1995) 5173-5179
9. Pogo B.G., Melana S.M., Holland J.F., Mandeli J.F., Pilotti S., Casalini P., and Menard S. Sequences homologous to the mouse mammary tumor virus env gene in human breast carcinoma correlate with overexpression of laminin receptor. Clin. Cancer Res. 5 (1999) 2108-2111
10. Melana S.M., Picconi M.A., Rossi C., Mural J., Alonio L.V., Teyssie A., Holland J.F., and Pogo B.G. Detection of murine mammary tumor virus (MMTV) env gene-like sequences in breast cancer from Argentine patients. Medicina (B Aires) 62 (2002) 323-327
11. Holland J.F., Melana S., Wang Y., Fernandez-Cobo M., Jiang J.D., and Pogo B.G. Human mammary tumor virus (HMTV) is horizontally, not vertically transmitted. Proc. Am. Soc. Clin. Oncol. 22 (2003) 873
12. Ford C.E., Tran D., Deng Y., Ta V.T., Rawlinson W.D., and Lawson J.S. Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. Clin. Cancer Res. 9 (2003) 1118-1120
13. Luo T., Wu X.T., Zhang M.M., and Qian K. Study of mouse mammary tumor virus-like gene sequences expressing in breast tumors of Chinese women. Sichuan Da Xue Xue Bao Yi Xue Ban 37 (2006) 844-846
14. Levine P.H., Pogo B.G., Klouj A., Coronel S., Woodson K., Melana S.M., Mourali N., and Holland J.F. Increasing evidence for a human breast carcinoma virus with geographic patterns. Cancer 101 (2004) 721-726
15. Tabbane F., Muenz L., Jaziri M., Cammoun M., Belhassen S., and Mourali N. Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia. Cancer 40 (1977) 376-382
16. Mourali N., Muenz L.R., Tabbane F., Belhassen S., Bahi J., and Levine P.H. Epidemiologic features of rapidly progressing breast cancer in Tunisia. Cancer 46 (1980) 2741-2746
17. Levine P.H., Steinhorn S.C., Ries L.G., and Aron J.L. Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) Program. J. Natl. Cancer. Inst. 74 (1985) 291-297
18. Maalej M., Frikha H., Ben Salem S., Daoud J., Bouaouina N., Ben Abdallah M., and Ben Romdhane K. Breast cancer in Tunisia: clinical and epidemiological study. Bull. Cancer 86 (1999) 302-306
19. Ben Ahmed S., Aloulou S., Bibi M., Landolsi A., Nouira M., Ben Fatma L., Kallel L., Gharbi O., Korbi S., Khairi H., and Kraiem C. Breast cancer prognosis in Tunisian women: analysis of a hospital series of 729 patients. Santé Publique 14 (2002) 231-241
20. J. Ferlay, F. Bray, P. Pisani, D.M. Parkin, GLOBOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5, version 2.0 IARC Press, Lyon, 2004.
21. Tavassoli F.A., and Devilee P. Pathology and Genetics of Tumors of the Breast and Female Genital Organs, WHO Classification of Tumors (2003), IARC Press
22. Elston C.W., and Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term followup. Histopathology 19 (1991) 403-410
23. Bauer H.M., Ting Y., Greer C.E., Chambers J.C., Tashiro C.J., Chimera J., Reingold A., and Manos M.M. Genital human papillomavirus infection in female university students as determined by a PCR based method. JAMA 265 (1991) 472-477
24. Saiki R.K., Bugawan T.L., Horn G.T., Mullis K.B., and Erlich H.A. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324 (1986) 13-19
25. Faedo M., Ford C.E., Mehta R., Blazek K., and Rawlinson W.D. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer. Clin. Cancer Res. 10 (2004) 4417-4419
26. Ford C.E., Faedo M., Crounch R., Lawson J.S., and Rawlinson W.D. Progression from normal breast pathology to breast cancer is associated with increasing prevalence of mouse mammary tumor virus-like sequences in man and women. Cancer Res. 64 (2004) 4755-4759
27. Remmele W., and Stegner H.E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER ICA) in breast cancer tissue. Pathologe 8 (1987) 138-140
28. Jacobs T.W., Gown A.M., Yaziji H., Barnes M.J., and Schnitt S.J. Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States food and drug administration approved scoring system. J. Clin. Oncol. 17 (1999) 1983-1987
29. M. Hachana, M. Trimeche, S. Ziadi, K. Amara, S. Korbi, Evidence for a role of the Simian Virus 40 in human breast carcinomas, Breast Cancer Res. Treat. (2008), doi: 10.1007/s10549-008-9901-z.
30. Melana S.M., Holland J.F., and Pogo B.G. Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals. Clin. Cancer Res. 7 (2001) 283-284
31. Ono M., Yasunaga T., Miyata T., and Ushikubo H. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J. Virol. 60 (1986) 589-598
32. Stewart T.H., Sage R.D., Stewart A.F., and Cameron D.W. Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus. Br. J. Cancer 82 (2000) 446-451
33. Imai S. Mouse mammary tumor virus and mammary tumorigenesis in wild mice. Pathol. Int. 46 (1996) 919-932
34. Wang Y., Pelisson I., Melana S.M., Go V., Holland J.F., and Pogo B.G. MMTV-like env gene sequences in human breast cancer. Arch. Virol. 146 (2001) 171-180
35. Indik S., Gunzburg W.H., Salmons B., and Rouault F. Mouse mammary tumor virus infects human cells. Cancer Res. 65 (2005) 6651-6659
36. Etkind P., Du J., Khan A., Pillitteri J., and Wiernik P.H. Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin. Cancer Res. 6 (2000) 1273-1278
37. Zangen R., Harden S., Cohen D., Parrella P., and Sidransky D. Mouse mammary tumor-like env gene as a molecular marker for breast cancer?. Int. J. Cancer 102 (2002) 304-307
38. Witt A., Hartmann B., Marton E., Schreiber M., and Kubista E. The mouse mammary tumor virus-like env gene sequence is not detectable in breast cancer tissue of Austrian patients. Oncology Rep. 10 (2003) 1025-1029
39. Mant C., Gillett C.D., Arrigo C., and Cason J. Human murine mammary tumor virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cell lines or biopsies. Virology 318 (2004) 393-403
40. Lawson J., Dinh D., Tran D., Ford C., and Rawlinson W. Elevated expression of the tumor suppressing protein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer. Breast Cancer Res. Treat. 87 (2004) 13-17
41. Wang Y., Melana S.M., Baker B., Bleiweiss I., Fernandez-Cobo M., Mandeli J.F., Holland J.F., and Pogo B.G. High prevalence of MMTV-like env gene sequences in gestatisonal breast cancer. Med. Oncol. 20 (2003) 233-236
42. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., and Ullrich A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707-712
43. Bieche I., and Lidereau R. Genetic alterations in breast cancer. Genes Chromosomes Cancer 4 (1995) 227-251
44. Yu D., and Hung M.C. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19 (2000) 6115-6121
45. Yu D., Suen T.C., Yan D.H., Chang L.S., and Hung M.C. Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products. Proc. Natl. Acad. Sci. USA 87 (1990) 4499-4503
46. Lin Y.C., Peng J.M., and Wang W.B. The N-terminal common domain of simian virus 40 large T and small t antigens acts as a transformation suppressor of the HER-2/neu oncogene. Oncogene 19 (2000) 2704-2713
47. Xing X., Wang S.C., Zou Y., Xia X.Y., Shao R., Kwong K.Y., Yu Z., Zhang S., Miller S., Huang L., and Hung M.C. The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nat. Med. 6 (2000) 189-195
48. Chuang T.C., Way T.D., Lin Y.S., Lee Y.C., Lawc S.L., and Kao M.C. The Epstein-Barr virus nuclear antigen-1 may act as a transforming suppressor of the HER2/neu oncogene. FEBS Lett. 532 (2002) 135-142
49. Chuang T.C., Yu Y.H., Lin Y.S., Wang S.S., and Kao M.C. The N-terminal domain of SV40 large T antigen represses the HER2/neu-mediated transformation and metastatic potential in breast cancer. FEBS Lett. 511 (2002) 46-50
50. Lawson J.S., Tran D., and Rawlinson W.D. From Bittner to Barr: a viral, diet and hormone breast cancer aetiology hypothesis. Breast Cancer Res. 3 (2000) 81-85